{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:08:39Z","timestamp":1792724919386,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.xphs.2024.11.016","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T16:21:27Z","timestamp":1733156487000},"page":"1061-1067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Storage stability and solution binding affinity of an Fc-fusion mimetic"],"prefix":"10.1016","volume":"114","author":[{"given":"Sama","family":"Prikalkhoran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Guiliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6612-1628","authenticated-orcid":false,"given":"Hanieh","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.xphs.2024.11.016_bib0001","doi-asserted-by":"crossref","first-page":"810","DOI":"10.4161\/mabs.28832","article-title":"Therapeutic Fc-Fusion proteins: edited by Steven M Chamow, Thomas Ryll, Henry B Lowman and Deborah Farson","volume":"6","author":"Ultee","year":"2014","journal-title":"MAbs"},{"issue":"1","key":"10.1016\/j.xphs.2024.11.016_bib0002","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jssc.202000765","article-title":"Therapeutic Fc-fusion proteins: current analytical strategies","volume":"44","author":"Duivelshof","year":"2021","journal-title":"J Sep Sci"},{"issue":"4","key":"10.1016\/j.xphs.2024.11.016_bib0003","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40259-015-0133-6","article-title":"Fusion proteins for half-life extension of biologics as a strategy to make biobetters","volume":"29","author":"Strohl","year":"2015","journal-title":"BioDrugs"},{"issue":"9","key":"10.1016\/j.xphs.2024.11.016_bib0004","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/nbt1126","article-title":"Selecting and screening recombinant antibody libraries","volume":"23","author":"Hoogenboom","year":"2005","journal-title":"Nat Biotechnol"},{"issue":"7","key":"10.1016\/j.xphs.2024.11.016_bib0005","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/pro.2684","article-title":"Advanced protein formulations","volume":"24","author":"Wang","year":"2015","journal-title":"Protein Sci"},{"issue":"49","key":"10.1016\/j.xphs.2024.11.016_bib0006","first-page":"11724","article-title":"Physical instability of a therapeutic Fc fusion protein: domain contributions to conformational and colloidal stability","volume":"48","author":"Cordes","year":"2009","journal-title":"J Pharm Sci"},{"issue":"5844","key":"10.1016\/j.xphs.2024.11.016_bib0007","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.xphs.2024.11.016_bib0008","unstructured":"EMA (European Medicines Agency), Assessment Report For Aflibercept (EMA\/646256\/2012), European Medicines Agency Committee for Medicinal Products for Human Use, Editor., 2012, p. 83. Available from: https:\/\/www.ema.europa.eu\/en\/homepage"},{"issue":"1","key":"10.1016\/j.xphs.2024.11.016_bib0009","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1038\/s41598-022-06831-2","article-title":"The sterility, stability and efficacy of repackaged ziv-aflibercept for intravitreal administration","volume":"12","author":"Juhong","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2024.11.016_bib0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejpb.2016.09.003","article-title":"Study of stability and biophysical characterization of ranibizumab and aflibercept","volume":"108","author":"Moreno","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2024.11.016_bib0011","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ijbiomac.2021.03.020","article-title":"Analytical comparability assessment on glycosylation of ziv-aflibercept and the biosimilar candidate","volume":"180","author":"Shen","year":"2021","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"10.1016\/j.xphs.2024.11.016_bib0012","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1039\/C6BM00077K","article-title":"Fc-fusion mimetics","volume":"4","author":"Khalili","year":"2016","journal-title":"Biomater Sci"},{"issue":"11","key":"10.1016\/j.xphs.2024.11.016_bib0013","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1021\/bc400246z","article-title":"Fab-PEG-Fab as a potential antibody mimetic","volume":"24","author":"Khalili","year":"2013","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.xphs.2024.11.016_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2020.112933","article-title":"Using different proteolytic enzymes to digest antibody and its impact on stability of antibody mimetics","volume":"489","author":"Khalili","year":"2021","journal-title":"J Immunol Methods"},{"issue":"11","key":"10.1016\/j.xphs.2024.11.016_bib0015","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1021\/jo960057x","article-title":"Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. Studies on direct and indirect reductive amination procedures (1)","volume":"61","author":"AF","year":"1996","journal-title":"J Org Chem"},{"issue":"1","key":"10.1016\/j.xphs.2024.11.016_bib0016","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/s41467-020-15642-w","article-title":"Quantifying the heterogeneity of macromolecular machines by mass photometry","volume":"11","author":"Sonn-Segev","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.xphs.2024.11.016_bib0017","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10719-023-10126-7","article-title":"Mass photometry: a powerful tool for carbohydrates-proteins conjugation monitoring and glycoconjugates molecular mass determination","volume":"40","author":"Wu","year":"2023","journal-title":"Glycoconj J"},{"key":"10.1016\/j.xphs.2024.11.016_bib0018","unstructured":"https:\/\/www.agilent.com\/en\/product\/biopharma-hplc-analysis\/aggregate-fragment-analysis\/advancebio-sec"},{"issue":"4","key":"10.1016\/j.xphs.2024.11.016_bib0019","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1089\/adt.2011.0380","article-title":"Molecular interaction studies using microscale thermophoresis","volume":"9","author":"Jerabek-Willemsen","year":"2011","journal-title":"Assay Drug Dev Technol"},{"key":"10.1016\/j.xphs.2024.11.016_bib0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ncomms1093","article-title":"Protein-binding assays in biological liquids using microscale thermophoresis","volume":"1","author":"Wienken","year":"2010","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.xphs.2024.11.016_bib0021","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1002\/cpz1.14","article-title":"N-terminal protein labeling with N-hydroxysuccinimide esters and microscale thermophoresis measurements of protein-protein interactions using labeled protein","volume":"1","author":"Jiang","year":"2021","journal-title":"Curr Protoc"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924005392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924005392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T22:07:45Z","timestamp":1742681265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924005392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0022354924005392"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.11.016","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Storage stability and solution binding affinity of an Fc-fusion mimetic","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}